This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Achim Geiser, Ph.D.
Synthetic Molecules Technical Development, External Technical Oversight Manager at F Hoffmann-La Roche Ltd
Speaker

Profile

Achim received his Ph.D. at the University of Heidelberg, He has over 23 years of professional experience as process chemist, in API sourcing and as coordinator of chemical development projects at 3rd parties. In 2012, Achim joined Roche's External Technical Oversight team, and since six years he is focussed on managing oligonucleotide CDMO activities.

Agenda Sessions

  • Application of Bioburden Control in Oligonucleotide Manufacturing

    09:20